CLL Treatments Shift Significantly at VHA From 2013-2018

DENVER, CO – Since the first novel agent was approved for use in chronic lymphocytic leukemia patients in 2014, how have treatment regimens changed at the VHA? That was the question behind a presentation at the recent 2020 American Society of Clinical Oncologists...

Agent Orange Exposure Appears to Worsen MGUS Progression

DETROIT - Agent Orange exposure by military personnel has been linked with multiple malignant and nonmalignant conditions, including monoclonal gammopathy of undetermined significance. MGUS is an indolent, premalignant plasma cell disorder with the potential of...